A comment on metformin and COVID-19 with regard to "Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy".

Authors :: Al-Salameh A
Wiernsperger N
Cariou B
Lalau JD
Source :: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2022 Sep; Vol. 24 (9), pp. 1888-1893. Date of Electronic Publication: 2022 May 25.
Publication Year :: 2022

Subjects :: Hospitalization
Humans
Hypoglycemic Agents adverse effects
Retrospective Studies
SARS-CoV-2
COVID-19 epidemiology
Diabetes Mellitus, Type 2 complications
Diabetes Mellitus, Type 2 drug therapy
Diabetes Mellitus, Type 2 epidemiology
Metformin therapeutic use

Full Text Access

Tools